Status:
ACTIVE_NOT_RECRUITING
Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
Lead Sponsor:
University of Arkansas
Conditions:
Prostate Cancer
Eligibility:
MALE
35-85 years
Brief Summary
The purpose of this research study is to compare profiles in the blood and tears of patients with and without prostate cancer with the goal of developing a method of separating men with aggressive and...
Eligibility Criteria
Inclusion
- Male, 35-85 years old
- Patients who present for the evaluation of an abnormal exam or test (elevated PSA, abnormal DRE, etc.)
- Patients who present for the evaluation of a palpable nodule or induration on prostate exam
- Patients who meet the requirements of Group 1, 2, or 3 of the protocol
Exclusion
- Patient \< 35 or \> 85 years of age
- Concurrent eye infection or trauma, including active conjunctivitis
- Abnormal production of tears (too much or too little)
- Any other conditions the PI or staff feels will not fulfill the criteria for study entry or will place the subject in a harmful environment
- Atypia on prostate biopsy report
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01514669
Start Date
January 1 2012
End Date
February 1 2027
Last Update
October 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States, 72205